Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

The Efficacy of Nebulized 3 Percent Hypertonic Saline Solution and Fenoterol in Infants with Bronchiolitis

영아 세기관지염에서 3% 고장성 식염액과 Fenoterol 병용흡입 치료의 효과

  • Received : 2005.01.27
  • Accepted : 2005.03.07
  • Published : 2005.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : To evaluate the effect of inhaled hypertonic saline solution in hospitalized infants with bronchiolitis. Methods : A randomized double blind trial was performed from October 2003 to May 2004. A total of eighty patients <1 year of age with a clinical diagnosis of acute viral bronchiolitis were enrolled and assigned to receive either of the following : inhalation of 2 mL(0.5 mg) fenoterol added to 2 mL of 0.9 percent saline solution(group 1; n=40) or 2 mL(0.5 mg) fenoterol added to 2 mL of 3 percent saline solution(group 2; n=40). This therapy was repeated at six hours interval after admission. They were evaluated daily just before and 20 minutes after nebulization. The outcome measures included changes in clinical severity score(based on respiratory rate, presence of wheezing, retraction, and general condition) after nebulization and duration of hospitalization. Results : In the clinical severity score, a significant improvement was observed during the 72 hours of hospitalization in both groups(P<0.05). The basic clinical severity scores before inhalation were decreased significantly faster in group 2 as compared to group 1 on each day of treatment(P<0.05). The mean duration of hospital stay was significantly reduced in group 2 than group 1($5.9{\pm}1.9days$ versus $7.4{\pm}2.0days$, P<0.05). No adverse effects were associated with inhaled therapy. Conclusion : These results suggest that a nebulized 3 percent saline solution plus 0.5 mg fenoterol may be more effective than a 0.9 percent saline solution plus 0.5 mg fenoterol in accelerating the clinical recovery of infants with viral bronchiolitis.

목 적 : 급성 세기관지염에 대한 치료로 보조 요법에 더해 기관지 확장제 흡입치료의 효과가 많이 보고되고 있다. 세기관지의 폐색에는 평활근의 수축이 관여하지만 어린 영아에서는 기관지 점막의 부종과 점액이나 상피세포 탈락물의 축적이 더 중요한 원인이기에, 본 질환으로 입원한 영아에서 ${\beta}_2$ 자극제와 정상 식염액을 혼합하여 흡입하는 대신, 점막 부종을 감소시키고 기도 축적물의 제거를 향상시킬 수 있는 고장성 식염액을 혼합하여 흡입했을 때의 치료효과를 알아보고자 하였다. 방 법 : 2003년 10월부터 2004년 5월까지 본원에 급성 세기관지염으로 입원한 1세 미만 환아 83명을 대상으로 하였다. 환아는 무작위로 두 그룹으로 나뉘어 입원과 동시에 초기 상태 평가가 이루어진 후 흡입 치료를 받았다. 치료는 이중 맹검법을 사용하여 fenoterol 2 mL(0.5 mg)에 0.9% saline solution 2 mL를 혼합하거나 fenoterol 2 mL에 3% saline solution 2 mL를 혼합하여 네뷰라이져로 6시간 간격으로 하루 4회 흡입하도록 하였다. 24, 48, 72시간째 흡입 전과 흡입 후 20분에 각각의 임상평가 점수를 측정하여 시간의 경과에 따른 변화를 검토하였고, 두 군의 총 입원일수도 비교하였다. 결 과 : 입원 72시간 동안, 두 그룹의 흡입 치료 직전의 임상평가 점수는 각각 시간이 지남에 따라 통계학적으로 유의하게 향상되었으며(P<0.05), 이는 3% 식염액 흡입군에서 유의하게 더 현저하였다(P<0.05). 평균 입원 일수는 0.9% 식염액 흡입군과 3% 식염액 흡입군 각각에서 $7.4{\pm}2.0$일과 $5.9{\pm}1.9$일로 두군간에 유의한 차이를 보였다(P<0.05). 흡입 치료와 관련된 부작용은 관찰되지 않았다. 결 론 : 급성 세기관지염으로 입원한 영아의 치료에서 3% saline solution에 혼합한 fenoterol 흡입 치료는 0.9% saline solution에 혼합한 fenoterol에 비해 더 효과적으로 임상 증상을 호전시켰다.

Keywords

References

  1. Darville T, Yamauchi T. Respiratory syncytial virus. Pediatr Rev 1998;19:55-6l https://doi.org/10.1542/pir.19-2-55
  2. Welliver JR, Welliver RC. Bronchiolitis. Pediatr Rev 1993; 14:134-9 https://doi.org/10.1542/pir.14-4-134
  3. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28 https://doi.org/10.1056/NEJM200106213442507
  4. Smith DW, Frankel LR, Mathers LH, Tang ATS, Ariagno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991;325:24-9 https://doi.org/10.1056/NEJM199107043250105
  5. Moler FW, Steinhart CM, Ohmit SE, Stidham GL. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. J Pediatr 1996;128:442-8 https://doi.org/10.1016/S0022-3476(96)70313-X
  6. Guerguerian A-M, Gauthier M, Lebel MH, Farrell CA, Lacroix J. Ribavirin in ventilated respiratory syncytial virus bronchiolits : a randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999;160:829-34 https://doi.org/10.1164/ajrccm.160.3.9810013
  7. Hall CB, McBride JT, Gala CL. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 1985;254:3047-5l https://doi.org/10.1001/jama.254.21.3047
  8. McDonald NE, Hall CB, Suffin SC. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982;307:397-400 https://doi.org/10.1056/NEJM198208123070702
  9. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. cMenon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995;126: 1004-7 https://doi.org/10.1016/S0022-3476(95)70234-2
  10. Bertrand P, Aranibar H, Castro E, Sanchez I. Efficacy of nebulized epinephrine vs salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001;31:284-8 https://doi.org/10.1002/ppul.1040
  11. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118:807-11 https://doi.org/10.1016/S0022-3476(05)80051-4
  12. Schuh S, Canny G, Reisman JJ, Kerem E, Bentur L, Petrie M, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr 1990;117:633-7 https://doi.org/10.1016/S0022-3476(05)80706-1
  13. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline m cystic fibrosis. Pediatr Pulmonol 1996; 21:77-83 https://doi.org/10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M
  14. Riedler J. Reade T, Button B, Robertson CF. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J Paediatr Child Health 1996;32:48-50 https://doi.org/10.1111/j.1440-1754.1996.tb01541.x
  15. Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PTP. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996;153:1503-9 https://doi.org/10.1164/ajrccm.153.5.8630593
  16. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997;52:900-3 https://doi.org/10.1136/thx.52.10.900
  17. Robinson M, Daviskas E, Eberl S, Baker J, Chan HK, Anderson SD, et al. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur Respir J 1999;14:678-85 https://doi.org/10.1034/j.1399-3003.1999.14c30.x
  18. King M, Dasgupta B, Tomkiewicz RP, Brown NE. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am J Respir Crit Care Med 1997;156;173-7 https://doi.org/10.1164/ajrccm.156.1.9512074
  19. Dasgupta B, Tomkiewicz RP, Brown NE, King M. Combined effect of hypertonic saline and rhDNase on cystic fibrosis sputum in vitro. Pediatr Pulmonol 1995;20(Suppl 12):A201-36
  20. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110: 1189-93 https://doi.org/10.1097/00005537-200007000-00023
  21. Wang EEL, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992;145:106-9 https://doi.org/10.1164/ajrccm/145.1.106
  22. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptom. Chest 2002;122:2015-20 https://doi.org/10.1378/chest.122.6.2015
  23. Radford M. Effect of salbutamol in infants with wheezy bronchitis. Arch Dis Child 1975;50:535-8 https://doi.org/10.1136/adc.50.7.535
  24. Rutter N, Milner AD, Hiller EJ. Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child 1975;50:719-22 https://doi.org/10.1136/adc.50.9.719
  25. Folkesson HG, Kheradmand F, Matthay MA. The effect of salt water on alveolar epithelial barrier function. Am J Respir Crit Care Med 1994;150:1555-63 https://doi.org/10.1164/ajrccm.150.6.7952614
  26. Boek WM, Keles N, Graamans K, Huizing EH. Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope 1999;109:396-9 https://doi.org/10.1097/00005537-199903000-00010
  27. Duchateau GSMJE, Graamans K, Zuidema J. Merkus FWHM. Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers. Laryngoscope 1985; 95:854-9
  28. Daviskas E, Anderson SD, Gonda I, Eberl S, Meikle S, Seale JP, et al. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J 1996;9:725-32 https://doi.org/10.1183/09031936.96.09040725
  29. Nasr SZ, Strouse PJ, Soskoline E, Maxvold NJ, Garver KA, Rubin BK, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest 2001;120:203-8 https://doi.org/10.1378/chest.120.1.203
  30. Angle N, Hoyt DB, Coimbra R, Liu F, Herdon-Remelius C, Loomis W, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutophil activation after hemorrhagic shock. Shock 1998;9:164-70 https://doi.org/10.1097/00024382-199803000-00002
  31. Angle N, Hoyt DB, Cabello-Passim R, Herdon-Remelius C, Loomis W, Junger WG. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma 1998;45:7-12 https://doi.org/10.1097/00005373-199807000-00002
  32. Murao Y, Hoyt DB, Loomis W, Namiki S, Patel N, Wolf P, et al. Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage? Shock 2000;14: 18-23 https://doi.org/10.1097/00024382-200014010-00004